|
Volumn 31, Issue 3, 2000, Pages 217-218
|
Is interferon therapy in pediatric chronic hepatitis B infection warranted?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
HEPATITIS B(E) ANTIBODY;
HEPATITIS B(E) ANTIGEN;
INTERFERON;
LAMIVUDINE;
VIRUS DNA;
ADOLESCENT;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG EFFICACY;
HEPATITIS B;
HUMAN;
IMMUNOTHERAPY;
INFLUENZA;
INJECTION PAIN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LONG TERM CARE;
MULTICENTER STUDY;
PEDIATRICS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
SHORT SURVEY;
VIRUS EXCRETION;
ADOLESCENT;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
LAMIVUDINE;
LONGITUDINAL STUDIES;
DNA VIRUSES;
|
EID: 0033851749
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/00005176-200009000-00001 Document Type: Short Survey |
Times cited : (2)
|
References (0)
|